LeafNLP Demos
Back to explore

Report #2864990

Received Oct 10, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
82 yrs
State
NC
Recovered
Unknown
Vaccinated
Sep 22, 2025
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK52Z52—

Symptoms (1)

Extra dose administered

Symptom narrative

Arexvy extra dose administration; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 52Z52, expiry date 16-OCT-2025) for prophylaxis. Previously administered products included Arexvy (received unknown dose on an unknown date). On 22-SEP-2025, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced extra dose administered (Verbatim: Arexvy extra dose administration). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date 23-SEP-2025 The reporter asked for safety or efficacy data on the administration of an extra dose of Arexvy. The reporter consented to follow up.